Tue, Jul 22, 2014, 11:36 AM EDT - U.S. Markets close in 4 hrs 24 mins

Recent

% | $
Click the to save as a favorite.

InterCore, Inc. Message Board

  • stock4you2win stock4you2win Dec 16, 2004 4:38 PM Flag

    "New Report just out > 12/16/04 4:10p

    December 16, 2004, 4:10PM ET 'UPDATE LIFEPOINT INC (AMEX:LFP)- Strong Buy, we believe the current price of $0.29 doesn't reflect the prospects of the recent FDA news >http://biz.yahoo.com/bw/041201/15235_1.html ,Note: stock had a sharp rally to $0.44c & is oversold at current levels, Target 30Day $0.45 12Month $0.80, Notes from Linda H. Masterson as she Retires as President and CEO of LifePoint
    DEC 14/04
    "Today, LifePoint's balance sheet is strong; the Company has no debt and the Company recently completed a $4 million financing," said Ms. Masterson. "In addition, we have just received two FDA clearances for a product that is now generating sales. The fact is that LifePoint is now in the strongest position it's ever been, allowing me the opportunity to join my husband in retirement. I look forward to the future success of the LifePoint team under the excellent direction of the current Board of Directors.

    "I am most proud of the fact that we have designed, developed, and are now manufacturing and marketing a very unique product--the IMPACT� Test System," added Ms. Masterson. "I believe that this product will be the cornerstone of a very successful company. The IMPACT Test System is the first diagnostic product which the FDA has reviewed and cleared that provides fully integrated sample collection and processing, as well as chemistry test analysis and results. While developing this novel product from concept, LifePoint has over 20 patents issued or pending."
    WWW PENNYSTOCKSDAILY COM.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
ICOR
1.220.00(0.00%)Jul 21 12:05 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.